NaturalNews.com By Zoey Sky
(Natural News) The coronavirus (COVID-19) pandemic continues to ravage countries across the world, with desperate people counting on a vaccine that can help protect them from this infectious disease. And yet despite warnings from health experts about potential negative side effects, Moderna Inc. has already begun testing its experimental coronavirus vaccine on kids aged 12 to 17.
Moderna’s vaccine to be completed by 2022
According to a press release from the biotechnology company, the phase II/III trial will involve an estimated 3,000 volunteers aged 12 to 17.
The researchers will give half of the volunteers two shots of Moderna’s immunization or mRNA-1273 four weeks apart. Meanwhile, the rest of the participants will receive saltwater placebos.
The scientists claim that they will monitor the safety and efficacy of the vaccine in children. All volunteers will be followed for 12 months after the second inoculation….
